Recent News

• 03.05.2025 - Paysign to Attend Asembia Specialty Pharmacy Summit, April 27-May 01, 2025
• 02.27.2025 - Paysign to Host Fourth Quarter and Full Year 2024 Earnings Call
• 02.26.2025 - Paysign is a Sponsor at ACCESS USA 2025, March 18-20, Philadelphia, PA
• 02.10.2025 - Paysign is Attending the Pharmaceutical Care Management Association Business Forum 2025, Orlando, FL
• 02.04.2025 - Paysign Announces 2024 Performance Analysis of Patient Affordability Solutions
• 02.04.2025 - Paysign Announces 2024 Performance Analysis of Patient Affordability Solutions
• 11.05.2024 - Paysign, Inc. Reports Third Quarter 2024 Financial Results

Recent Filings

• 02.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.10.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.23.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.15.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.15.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.31.2024 - 4 Statement of changes in beneficial ownership of securities
• 12.31.2024 - 4 Statement of changes in beneficial ownership of securities
• 12.11.2024 - 4 Statement of changes in beneficial ownership of securities
• 11.20.2024 - 4 Statement of changes in beneficial ownership of securities
• 11.14.2024 - SC 13G/A Statement of Beneficial Ownership by Certain Investors